McB Special Capsule
McB Special Capsule
This is the latest product from Hirado Momordica Charantia (patented), an evolved form of the natural herb Momordica charantia (bitter melon), which has been enjoyed by the Incas since ancient times.
It is a nano-sized, more advanced version of conventional products, and is a vegetable-based soft capsule that dissolves in the intestines, making it a "nutritional functional food" that can be safely consumed by people of all ages and genders.
This is a highly recommended product that should be tried by many people, including those who are worried about being forgetful lately, those who are concerned about stress management, those undergoing drug treatment, and those who are worried about the future due to lifestyle-related diseases.
The high capabilities of McB have been demonstrated in a wide range of areas not only through the results of various analyses conducted since 2009, but also through various clinical trials and pilot tests conducted at medical schools and medical institutions since 2013.
***Ongoing human trials***
From 2021, "Cognitive function improvement human trial"
August 2022 ~ "Human clinical trials to suppress side effects of anti-cancer drugs and radiation therapy"
detail
| Daily Estimate |
|---|
| Take 4 capsules daily. It is recommended to take it in the morning and in the evening (on an empty stomach). |
| Contents |
| 120 tablets (PTP packaging) 1 box |
McB's discovery occurred in April 1979.
The developer, who was studying abroad at the Autonomous University of Mexico at the time, traveled to the village of Vilcabamba in Ecuador with just a backpack, inspired by his longing for a utopia in Central and South America.
At the time, the area was famous for its longevity. I was intrigued by the lifestyle of the residents, who were so free from illness, and I focused on the customs and ingredients that had been familiar to the area for many years.
Among them was a plant that they regularly ingested, ground up and applied.
After returning to Japan, I consulted a friend who majored in botany, and it turned out that the plant was the original species of Momordica charantia. 
Momordica charantia is a vine plant that grows and bears fruit. When the fruit is fully ripe, it splits open to reveal seeds with sweet pulp inside.
The seeds were eaten by migratory birds, and they spread throughout the world, giving rise to more than 400 species.
This fruit, known as bitter melon, is now enjoyed as a summer food ingredient in Japan.
According to an American doctor of agriculture, it contains 61 kinds of wonderful active ingredients. However, this fruit contains a lot of antipyretic ingredients (quinine), so people with digestive or circulatory disorders and pregnant women should not take it.
Therefore, in order to sell it as a food, the two research themes were to completely remove the antipyretic ingredients and to enhance other nutritional components.
Over the next 10 years, they were able to achieve this goal by developing a special cultivation method (patented) that does not use pesticides and improving the soil components, which they named "Hirado Tsurusou" and patented. They then commercialized it under the name "McB (an acronym for useful ingredient)."
The biggest point here is to preserve the active ingredients without destroying them. By making it nano-level, MacBee dissolves in the intestines and is absorbed efficiently through the gaps between cells, making it a better product than conventional products. Thanks to cutting-edge technology (#^.^#)
The high capabilities of McB have been revealed in a wide range of areas not only through various analytical results since 2009, but also through various clinical trials and pilot studies at medical schools and medical institutions since 2013, and excellent presentations about its capabilities have been made one after another at various academic conferences since 2019.
***Ongoing human clinical trials***
Human trials for improving dementia have been underway at the university since 2021!
From summer 2022: Part of clinical trials using humans to suppress side effects caused by anti-cancer drugs and radiation therapy
Antioxidant capacity: An indicator of the ability to suppress lifestyle-related diseases such as diabetes, high blood pressure, and obesity, which are risk factors for dementia, as well as oxidative stress and inflammation.
Inhibition rate of amyloid beta and phosphorylated tau: These are said to be the causative substances of dementia.
AGE production inhibition: an indicator of slowing down the aging process
Effect on type 2 diabetes Improved cognitive function in elderly people at a facility Data available Activation of intestinal epithelial cells Macrophage activation test (immunology)
Gluten reaction suppression, etc.
- Choosing a selection results in a full page refresh.
- Opens in a new window.